These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12607389)

  • 41. [The current pharmacotherapy of pulmonary arterial hypertension].
    Betkier-Lipińska K; Ryczek R; Cwetsch A
    Pol Merkur Lekarski; 2015 Jan; 38(223):34-8. PubMed ID: 25763586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful management of portopulmonary hypertension with beraprost.
    Kim EJ; Shin MS; Oh KY; Kim MG; Shin KC; Park YM; Kim BR; Chung WJ; Ahn TH; Choi IS; Shin EK
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1503-5. PubMed ID: 21389799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vasodilator therapy for primary pulmonary hypertension in children.
    Barst RJ; Maislin G; Fishman AP
    Circulation; 1999 Mar; 99(9):1197-208. PubMed ID: 10069788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The status of pulmonary arterial hypertension in 2008.
    Farber HW
    Circulation; 2008 Jun; 117(23):2966-8. PubMed ID: 18541751
    [No Abstract]   [Full Text] [Related]  

  • 45. Prostacyclin therapy for pulmonary arterial hypertension.
    Ruan CH; Dixon RA; Willerson JT; Ruan KH
    Tex Heart Inst J; 2010; 37(4):391-9. PubMed ID: 20844610
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nebulized prostacyclin for pulmonary hypertension: a step in the right direction.
    Wang A; Bashore TM
    Eur Heart J; 1997 Sep; 18(9):1364-5. PubMed ID: 9458437
    [No Abstract]   [Full Text] [Related]  

  • 47. Medical & surgical approaches to pulmonary hypertension.
    McLaughlin VV; Rich S
    Compr Ther; 1997 Sep; 23(9):612-6. PubMed ID: 9285162
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of inhaled treprostinil in patients with interstitial lung disease and pulmonary hypertension: to boldly go where no other pulmonary vasodilator has gone before?
    Piccari L; Wort SJ
    Thorax; 2024 Mar; 79(4):295-296. PubMed ID: 38307844
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment of primary pulmonary hypertension.
    Handa S
    Intern Med; 2002 Oct; 41(10):757-8. PubMed ID: 12412989
    [No Abstract]   [Full Text] [Related]  

  • 50. [Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension].
    Olschewski H; Walmrath D; Schermuly R; Ghofrani HA; Grimminger F; Seeger W
    Pneumologie; 1998 Jan; 52(1):3-7. PubMed ID: 9540363
    [No Abstract]   [Full Text] [Related]  

  • 51. [Vasodilators, modern therapeutic approach in pulmonary arterial hypertension].
    Gherasim L; Bogdan M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(2):97-102. PubMed ID: 6127777
    [No Abstract]   [Full Text] [Related]  

  • 52. Clevidipine (Cleviprex) for IV treatment of severe hypertension.
    Med Lett Drugs Ther; 2008 Sep; 50(1295):73-4. PubMed ID: 18800023
    [No Abstract]   [Full Text] [Related]  

  • 53. [Therapy of pulmonary arterial hypertension].
    Olschewski H; Ghofrani A; Enke B; Reichenberger F; Voswinckel R; Kreckel A; Ghofrani S; Wiedemann R; Schulz R; Grimminger F; Seeger W
    Internist (Berl); 2005 Mar; 46(3):341-9. PubMed ID: 15703889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pulmonary arterial hypertension: a current review of pharmacological management.
    Sahni S; Ojrzanowski M; Majewski S; Talwar A
    Pneumonol Alergol Pol; 2016; 84(1):47-61. PubMed ID: 26693827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension].
    Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337
    [No Abstract]   [Full Text] [Related]  

  • 56. High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy.
    Ozkan M; Dweik RA; Laskowski D; Arroliga AC; Erzurum SC
    Lung; 2001; 179(4):233-43. PubMed ID: 11891614
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beraprost sodium for pulmonary hypertension with congenital heart disease.
    Suzuki H; Sato S; Tanabe S; Hayasaka K
    Pediatr Int; 2002 Oct; 44(5):528-9. PubMed ID: 12225555
    [No Abstract]   [Full Text] [Related]  

  • 58. [Collagen diseases with pulmonary hypertension].
    Endo H; Tanaka S; Sakai M
    Nihon Rinsho Meneki Gakkai Kaishi; 2004 Jun; 27(3):127-36. PubMed ID: 15291249
    [No Abstract]   [Full Text] [Related]  

  • 59. [Pulmonary artery hypertension associated with connective tissue diseases].
    Sanchez O; Sitbon O; Garcia G; Jaïs X; Simonneau G; Humbert M
    Presse Med; 2003 May; 32(17):789-99. PubMed ID: 12856325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cutaneous hypersensitivity and eosinophilia associated with treprostinil.
    Das A; Shabbir A; Sehgal S; Highland KB
    Pulm Pharmacol Ther; 2015 Dec; 35():17-8. PubMed ID: 26407925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.